• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局部结直肠小细胞癌新辅助顺铂和依托泊苷治疗后病理完全缓解:病例报告。

Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report.

机构信息

Medical Oncology Department, Ramón y Cajal University Hospital, 28034 Madrid, Spain.

Ramón y Cajal Health Research Institute (IRYCIS), 28034 Madrid, Spain.

出版信息

Curr Oncol. 2023 Sep 14;30(9):8426-8433. doi: 10.3390/curroncol30090613.

DOI:10.3390/curroncol30090613
PMID:37754528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10528221/
Abstract

Extrapulmonary small-cell carcinoma (SCC) is a rare neoplasm that shares certain features with its pulmonary counterpart and occurs predominantly in the gastrointestinal tract (GIT). It is a high-grade and poorly differentiated neuroendocrine tumor, usually diagnosed in advanced stages, with a poor prognosis and few therapeutic options in that setting. This is a case report of a 77-year-old Spanish male patient with localized SCC of the colon, who presented a pathological complete response in the surgical specimen after neoadjuvant chemotherapy with cisplatin and etoposide. To date, 5 years after surgery, the patient remains without evidence of tumor recurrence. As clinical guidelines for the management of this entity are lacking, and therefore its management has not been standardized, an attempt to summarize the current evidence in the literature was made.

摘要

肺外小细胞癌(SCC)是一种罕见的肿瘤,与肺部 SCC 具有某些共同特征,主要发生在胃肠道(GIT)中。它是一种高级别、低分化的神经内分泌肿瘤,通常在晚期诊断,预后较差,在这种情况下治疗选择有限。这是一例 77 岁西班牙男性患者的病例报告,该患者患有局部结肠 SCC,在接受顺铂和依托泊苷新辅助化疗后,手术标本中出现了病理完全缓解。迄今为止,手术后 5 年,患者仍无肿瘤复发的迹象。由于缺乏针对该实体的临床管理指南,因此其管理尚未标准化,我们尝试总结了目前文献中的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9125/10528221/f88ab9f0a636/curroncol-30-00613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9125/10528221/2bad2515d573/curroncol-30-00613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9125/10528221/f88ab9f0a636/curroncol-30-00613-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9125/10528221/2bad2515d573/curroncol-30-00613-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9125/10528221/f88ab9f0a636/curroncol-30-00613-g002.jpg

相似文献

1
Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report.局部结直肠小细胞癌新辅助顺铂和依托泊苷治疗后病理完全缓解:病例报告。
Curr Oncol. 2023 Sep 14;30(9):8426-8433. doi: 10.3390/curroncol30090613.
2
Successful management of small cell neuroendocrine carcinoma of the ureter with neoadjuvant chemotherapy and adjuvant chemoradiation: case report and literature review.成功应用新辅助化疗和辅助放化疗治疗输尿管小细胞神经内分泌癌:病例报告及文献复习。
BMJ Case Rep. 2021 Aug 17;14(8):e240613. doi: 10.1136/bcr-2020-240613.
3
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder.由顺铂、依托泊苷和伊立替康组成的方案诱导原发性膀胱小细胞癌出现完全病理缓解。
Int J Urol. 2006 Sep;13(9):1251-3. doi: 10.1111/j.1442-2042.2006.01521.x.
4
A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.一项关于可切除食管小细胞神经内分泌癌患者根治性放化疗的回顾性研究。
Esophagus. 2020 Apr;17(2):135-140. doi: 10.1007/s10388-019-00686-9. Epub 2019 Jul 18.
5
Small cell carcinoma of the nasopharynx.鼻咽小细胞癌
Acta Otolaryngol. 2007 Feb;127(2):206-8. doi: 10.1080/00016480500401027.
6
Esophageal Neuroendocrine Carcinoma With Pathological Complete Response After Neoadjuvant Chemotherapy Followed by Robot-assisted Surgery: A Case Report.新辅助化疗后行机器人辅助手术治疗达到病理完全缓解的食管神经内分泌癌:病例报告。
Anticancer Res. 2023 Jul;43(7):3289-3293. doi: 10.21873/anticanres.16504.
7
Cisplatin and etoposide as first-line chemotherapy for poorly differentiated neuroendocrine carcinoma of the hepatobiliary tract and pancreas.顺铂和依托泊苷作为一线化疗药物用于治疗肝胆胰神经内分泌癌低分化患者。
Jpn J Clin Oncol. 2010 Apr;40(4):313-8. doi: 10.1093/jjco/hyp173. Epub 2010 Jan 4.
8
Gastric small cell carcinoma with marked response to neoadjuvant chemotherapy.对新辅助化疗有显著反应的胃小细胞癌。
Int J Clin Oncol. 2005 Oct;10(5):348-52. doi: 10.1007/s10147-005-0492-y.
9
Long-term survival of a patient with primary small cell neuroendocrine carcinoma of the maxillary sinus: a case report.上颌窦原发性小细胞神经内分泌癌患者的长期生存:一例报告
J Oral Maxillofac Surg. 2013 Aug;71(8):e248-52. doi: 10.1016/j.joms.2013.04.019.
10
Small cell neuroendocrine carcinoma of the urinary tract successfully managed with neoadjuvant chemotherapy.经新辅助化疗成功治疗的泌尿道小细胞神经内分泌癌
Case Rep Urol. 2013;2013:598325. doi: 10.1155/2013/598325. Epub 2013 Aug 18.

引用本文的文献

1
Successful outcome achieved with adjuvant chemotherapy with irinotecan plus cisplatin in rectal neuroendocrine carcinoma: a case report.伊立替康联合顺铂辅助化疗成功治疗直肠神经内分泌癌:一例报告
Surg Case Rep. 2024 Sep 19;10(1):220. doi: 10.1186/s40792-024-02010-9.

本文引用的文献

1
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study.塔拉拉单抗,一种首创的 DLL3 靶向双特异性 T 细胞衔接器,用于复发性小细胞肺癌:一项开放标签、I 期研究。
J Clin Oncol. 2023 Jun 1;41(16):2893-2903. doi: 10.1200/JCO.22.02823. Epub 2023 Jan 23.
2
ASO Author Reflections: Prognostic Factors in Gastrointestinal Extrapulmonary Small Cell Carcinoma Using Real-World Data.ASO作者反思:利用真实世界数据分析胃肠道肺外小细胞癌的预后因素
Ann Surg Oncol. 2022 Dec;29(13):8261-8262. doi: 10.1245/s10434-022-12441-z. Epub 2022 Aug 25.
3
Extrapulmonary Small Cell Carcinoma Presenting as an Orbital Mass: A Case Report.
表现为眼眶肿物的肺外小细胞癌:一例报告
Cureus. 2022 Jun 16;14(6):e26012. doi: 10.7759/cureus.26012. eCollection 2022 Jun.
4
Second-Generation Neuroendocrine Immunohistochemical Markers: Reflections from Clinical Implementation.第二代神经内分泌免疫组化标志物:临床应用的思考
Biology (Basel). 2021 Sep 5;10(9):874. doi: 10.3390/biology10090874.
5
The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5.世界卫生组织胃肠道神经内分泌肿瘤新分类以及生长抑素受体2和5的免疫组化表达
Exp Ther Med. 2021 Oct;22(4):1179. doi: 10.3892/etm.2021.10613. Epub 2021 Aug 13.
6
Small cell neuroendocrine carcinoma arising in cystic duplication of colon.
ANZ J Surg. 2022 Mar;92(3):608-610. doi: 10.1111/ans.17105. Epub 2021 Jul 28.
7
High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy.乳腺高级别神经内分泌癌,一线和维持免疫治疗。
Anticancer Drugs. 2022 Jan 1;33(1):91-93. doi: 10.1097/CAD.0000000000001126.
8
A phase II basket trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART) SWOG S1609: High-grade neuroendocrine neoplasm cohort.DART 研究:在罕见肿瘤中应用 Dual Anti-CTLA-4 和 Anti-PD-1 阻断的 II 期篮子试验(SWOG S1609):高级神经内分泌肿瘤队列。
Cancer. 2021 Sep 1;127(17):3194-3201. doi: 10.1002/cncr.33591. Epub 2021 Apr 21.
9
Small-cell lung cancer.小细胞肺癌。
Nat Rev Dis Primers. 2021 Jan 14;7(1):3. doi: 10.1038/s41572-020-00235-0.
10
Pulmonary neuroendocrine cells: physiology, tissue homeostasis and disease.肺神经内分泌细胞:生理学、组织稳态和疾病。
Dis Model Mech. 2020 Dec 21;13(12):dmm046920. doi: 10.1242/dmm.046920.